Aspirin Withdrawal Unlocks Safer Recovery for Heart Patients
High-risk heart patients show improved outcomes and reduced bleeding by over 50% when aspirin is withdrawn one month after PCI, with ticagrelor treatment alone, according…
High-risk heart patients show improved outcomes and reduced bleeding by over 50% when aspirin is withdrawn one month after PCI, with ticagrelor treatment alone, according…
Researchers unveil how the self-killing activity of bacteria can be harnessed in the fight against antibiotic resistance. Scientists at the Icahn School of Medicine at…
Study sheds light on TAAR1, pointing to potential enhancement opportunities in drug development. Researchers at the Icahn School of Medicine at Mount Sinai have uncovered…
Genomic ‘Tweezer’ Ushers In a New Era of Precision in Microbiome Research Innovative method holds the potential to reshape our understanding of bacteria’s role in…
Statistical technique enhances genetic disease prediction in non-European populations, addressing healthcare equity. A team of scientists from Icahn School of Medicine at Mount Sinai has…
A Mount Sinai study found that blocking an allergy pathway boosts antitumor immunity in lung cancer, with an allergy drug, dupilumab, enhancing the effectiveness of…
Researchers have revealed how the protein TIMP2 regulates brain plasticity, particularly in the hippocampus, offering new insights into treating age-related disorders like Alzheimer’s by targeting…
Harnessing the power of explainable AI, researchers have unveiled the first insights into the complex workings of deep-brain stimulation therapy for treatment-resistant depression. A team…
A recent study from the Icahn School of Medicine at Mount Sinai suggests that fasting could negatively affect immune cells, potentially increasing the risk of…
Dr. Eimear Kenny, a renowned professor of Medicine, Genetics, and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, has made substantial contributions…
Mount Sinai’s AI model, HeartBEiT, improves the accuracy and detail of ECG diagnoses, even for rare conditions with limited data. It interprets ECGs as language…
Wearable devices may be a means to monitor psychological states through effortless data collection using artificial intelligence. Researchers at Mount Sinai have shown that data…
Researchers at Mount Sinai have created a computational method that enables the identification of previously unknown genetic causes for primary lymphedema, thoracic aortic aneurysm disease,…
First U.S. study to show lower cardiac risk of cardiac events in patients following SARS-CoV-2 infection. Analyzing the most extensive datasets in the United States,…
Findings from novel analytic approach could contribute to discovery of new therapeutic targets for Alzheimer’s disease. Mount Sinai researchers have published a study today (February…
Patients experienced significant improvement in their symptoms, even up to 20 weeks after they had stopped taking the medication. Mount Sinai researchers have reported promising…
The new drug has been shown to be faster and has fewer negative side effects compared to the current standard treatment. A team of researchers…
Mount Sinai researchers have published one of the first studies to associate changes in blood gene expression during COVID-19 with “long COVID” in patients more…